Canadian trial prompts Bayer to halt marketing of anti-bleeding drug

FRANKFURT, Germany - Under government pressure, Bayer AG said Monday it halted worldwide sales of its antibleeding drug Trasylol after a Canadian clinical study found it could be linked to a higher risk of death than other drugs....More